Huaren Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300110.SZ

Huaren Pharmaceutical Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2023: USD 124.44 M

Huaren Pharmaceutical Co., Ltd. Total Non-Current Liabilities is USD 124.44 M for the year ending December 31, 2023, a 61.02% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
  • Huaren Pharmaceutical Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2022 was USD 77.28 M, a -19.15% change year over year.
  • Huaren Pharmaceutical Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2021 was USD 95.59 M, a 1,941.29% change year over year.
  • Huaren Pharmaceutical Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2020 was USD 4.68 M, a 4.36% change year over year.
  • Huaren Pharmaceutical Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2019 was USD 4.49 M, a -37.30% change year over year.
Key data
Date Total Non-Current Liabilities Shareholders' Equity Other Liabilities Total Liabilities
Market news
Loading...
Shenzhen Stock Exchange: 300110.SZ

Huaren Pharmaceutical Co., Ltd.

CEO Mr. Liang Hong
IPO Date Aug. 25, 2010
Location China
Headquarters High-tech Industrial Park
Employees 2,681
Sector Health Care
Industries
Description

Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. The company offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. It also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, anti-tumor, and carbohydrate metabolism; and medical instruments, such as disposable incision retractors, disposable cannula puncture devices disposable specimen extractors, abdominal suction tubes, incision retractor protectors, iodine solution protective caps, slip pads, respiratory oscillation expectoration machines, protective mask cup types, protective and foldable disposable masks, and medical protective masks. In addition, the company offers pharmaceutical packaging materials, including rubber stopper, carton, and membrane; rinsing fluid and API series products; and food and beverage, and medical skin care products. Huaren Pharmaceutical Co., Ltd. was founded in 1998 and is based in Qingdao, China.

StockViz Staff

January 15, 2025

Any question? Send us an email